Literature DB >> 19332030

Brain stress systems in the amygdala and addiction.

George F Koob1.   

Abstract

Dysregulation of the brain emotional systems that mediate arousal and stress is a key component of the pathophysiology of drug addiction. Drug addiction is a chronically relapsing disorder characterized by a compulsion to seek and take drugs and the development of dependence and manifestation of a negative emotional state when the drug is removed. Activation of brain stress systems is hypothesized to be a key element of the negative emotional state produced by dependence that drives drug-seeking through negative reinforcement mechanisms. The focus of the present review is on the role of two key brain arousal/stress systems in the development of dependence. Emphasis is placed on the neuropharmacological actions of corticotropin-releasing factor (CRF) and norepinephrine in extrahypothalamic systems in the extended amygdala, including the central nucleus of the amygdala, bed nucleus of the stria terminalis, and a transition area in the shell of the nucleus accumbens. Compelling evidence argues that these brain stress systems, a heretofore largely neglected component of dependence and addiction, play a key role in engaging the transition to dependence and maintaining dependence once it is initiated. Understanding the role of the brain stress and anti-stress systems in addiction not only provides insight into the neurobiology of the "dark side" of addiction but also provides insight into the organization and function of basic brain emotional circuitry that guides motivated behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332030      PMCID: PMC2774745          DOI: 10.1016/j.brainres.2009.03.038

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  96 in total

1.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

2.  Excessive ethanol drinking following a history of dependence: animal model of allostasis.

Authors:  A J Roberts; C J Heyser; M Cole; P Griffin; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-06       Impact factor: 7.853

3.  Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.

Authors:  Sonia Tucci; Survjit Cheeta; Pallab Seth; Sandra E File
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

4.  Relapse research and the Reasons for Drinking Questionnaire: a factor analysis of Marlatt's relapse taxonomy.

Authors:  W H Zywiak; G J Connors; S A Maisto; V S Westerberg
Journal:  Addiction       Date:  1996-12       Impact factor: 6.526

5.  The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats.

Authors:  Z W Brown; Z Amit
Journal:  Neurosci Lett       Date:  1977-09       Impact factor: 3.046

6.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

7.  Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization.

Authors:  B M Sharp; S G Matta
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

Review 8.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

9.  Intrinsic GABAergic neurons in the rat central extended amygdala.

Authors:  N Sun; M D Cassell
Journal:  J Comp Neurol       Date:  1993-04-15       Impact factor: 3.215

10.  A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence.

Authors:  B J Mason; E C Ritvo; R O Morgan; F R Salvato; G Goldberg; B Welch; E Mantero-Atienza
Journal:  Alcohol Clin Exp Res       Date:  1994-10       Impact factor: 3.455

View more
  170 in total

1.  Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.

Authors:  Antonia Serrano; Patricia Rivera; Francisco J Pavon; Juan Decara; Juan Suárez; Fernando Rodriguez de Fonseca; Loren H Parsons
Journal:  Alcohol Clin Exp Res       Date:  2011-12-05       Impact factor: 3.455

2.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

3.  The amygdala central nucleus: a new region implicated in habit learning.

Authors:  Jean-Marie N Maddux; Felipe L Schiffino; Stephen E Chang
Journal:  J Neurosci       Date:  2012-06-06       Impact factor: 6.167

4.  Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior.

Authors:  P Zill; V Vielsmeier; A Büttner; W Eisenmenger; F Siedler; B Scheffer; H-J Möller; B Bondy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-08-05       Impact factor: 5.270

5.  Responses of glial cells to stress and glucocorticoids.

Authors:  F Jauregui-Huerta; Y Ruvalcaba-Delgadillo; R Gonzalez-Castañeda; J Garcia-Estrada; O Gonzalez-Perez; S Luquin
Journal:  Curr Immunol Rev       Date:  2010-08-01

Review 6.  The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans.

Authors:  George A Kenna; Robert M Swift; Thomas Hillemacher; Lorenzo Leggio
Journal:  Neuropsychol Rev       Date:  2012-07-07       Impact factor: 7.444

7.  Harmonizing DTI measurements across scanners to examine the development of white matter microstructure in 803 adolescents of the NCANDA study.

Authors:  Kilian M Pohl; Edith V Sullivan; Torsten Rohlfing; Weiwei Chu; Dongjin Kwon; B Nolan Nichols; Yong Zhang; Sandra A Brown; Susan F Tapert; Kevin Cummins; Wesley K Thompson; Ty Brumback; Ian M Colrain; Fiona C Baker; Devin Prouty; Michael D De Bellis; James T Voyvodic; Duncan B Clark; Claudiu Schirda; Bonnie J Nagel; Adolf Pfefferbaum
Journal:  Neuroimage       Date:  2016-02-10       Impact factor: 6.556

8.  Central amygdala relaxin-3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats.

Authors:  Leigh C Walker; Hanna E Kastman; Elena V Krstew; Andrew L Gundlach; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

9.  Chromatin remodeling: a new landscape to treat harmful alcohol-use disorders.

Authors:  Vincent Warnault; Dorit Ron
Journal:  Future Med Chem       Date:  2013-11       Impact factor: 3.808

Review 10.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Philip H Smith; Kelly P Cosgrove; Yann S Mineur; Marina R Picciotto; Carolyn M Mazure; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.